Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2012 | 04:35am CET

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
02/16 ASAHI KASEI : Patent Issued for Organic Colored Microparticles, Diagnostic Reage..
02/15 ASAHI KASEI : and Bluestar plan joint venture for mPPE business in China
02/09 ASAHI KASEI : Patent Issued for Medical Material Employing Carboxymethyl Cellulo..
02/09 ASAHI KASEI : Japan`s Asahi Kasei to trial-market plant-derived nanofibers
02/08 ASAHI KASEI : Combine Solicitation - J-- Intent to Sole Source PM for Zoll Venti..
02/07 ASAHI KASEI : Home Order Trends – January 2017
02/07 ASAHI KASEI : to Relocate Head Office
02/03 ASAHI KASEI : Start-up of new production facility for Bemliese
02/02 ASAHI KASEI : Start-up of new production facility for Bemliese™
02/01 ASAHI KASEI CORPORATION : Asahi Kasei eröffnet Technologiezentrum für technische..
More news
Sector news : Commodity Chemicals - NEC
02/23DJLYONDELLBASELL INDUSTRIES : Files 8K - Other Events
02/23DJLYONDELLBASELL INDUSTRIES : Files 8K - Direct Or Off-Balance Sheet Financial Obl..
02/23DJLYONDELLBASELL INDUSTRIES : Files 8K - Entry Into Definitive Agreement
02/23DJLyondellBasell Files 8K - Changes Executive Management
02/23DJLYONDELLBASELL INDUSTRIES : Files 8K - Other Events
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
01/19 Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
2016 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
Advertisement
Financials ( JPY)
Sales 2017 1 861 237 M
EBIT 2017 -
Net income 2017 103 051 M
Debt 2017 247 236 M
Yield 2017 1,88%
P/E ratio 2017 15,04
P/E ratio 2018 14,37
EV / Sales 2017 0,97x
EV / Sales 2018 0,90x
Capitalization 1 551 995 M
More Financials
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 1 033  JPY
Spread / Average Target -6,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP8.16%13 834
AIR LIQUIDE-1.04%41 915
SHIN-ETSU CHEMICAL CO ..7.53%37 570
LYONDELLBASELL INDUSTR..8.57%37 206
PRAXAIR, INC.0.74%33 707
AIR PRODUCTS & CHEMICA..-2.41%30 650
More Results